{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T03:26:44Z","timestamp":1786678004059,"version":"build-2736575974"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":65,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Anesthesiol"],"DOI":"10.1186\/s12871-026-04010-8","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T03:34:32Z","timestamp":1781062472000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Considerations for diverse RYR1 variants in malignant hyperthermia susceptible patients: a report of two cases"],"prefix":"10.1186","volume":"26","author":[{"given":"Yan","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangjiang","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"issue":"4","key":"4010_CR1","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1097\/00000542-199404000-00008","volume":"80","author":"MG Larach","year":"1994","unstructured":"Larach MG, et al. A clinical grading scale to predict malignant hyperthermia susceptibility. Anesthesiology. 1994;80(4):771\u20139.","journal-title":"Anesthesiology"},{"issue":"4","key":"4010_CR2","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.bja.2018.06.028","volume":"121","author":"DM Miller","year":"2018","unstructured":"Miller DM, et al. Genetic epidemiology of malignant hyperthermia in the UK. Br J Anaesth. 2018;121(4):944\u201352.","journal-title":"Br J Anaesth"},{"issue":"4","key":"4010_CR3","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1177\/0310057X1504300415","volume":"43","author":"L Heytens","year":"2015","unstructured":"Heytens L, et al. The changing face of malignant hyperthermia: less fulminant, more insidious. Anaesth Intensive Care. 2015;43(4):506\u201311.","journal-title":"Anaesth Intensive Care"},{"issue":"5","key":"4010_CR4","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1097\/WCO.0000000000000592","volume":"31","author":"B De Wel","year":"2018","unstructured":"De Wel B, Claeys KG. Malignant hyperthermia: still an issue for neuromuscular diseases? Curr Opin Neurol. 2018;31(5):628\u201334.","journal-title":"Curr Opin Neurol"},{"issue":"6","key":"4010_CR5","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s12630-018-1108-0","volume":"65","author":"S Riazi","year":"2018","unstructured":"Riazi S, Kraeva N, Hopkins PM. Updated guide for the management of malignant hyperthermia. Can J Anaesth. 2018;65(6):709\u201321.","journal-title":"Can J Anaesth"},{"issue":"1","key":"4010_CR6","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/ALN.0000000000001878","volume":"128","author":"S Riazi","year":"2018","unstructured":"Riazi S, Kraeva N, Hopkins PM. Malignant Hyperthermia in the Post-Genomics Era: New Perspectives on an Old Concept. Anesthesiology. 2018;128(1):168\u201380.","journal-title":"Anesthesiology"},{"issue":"1","key":"4010_CR7","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/bja\/aer132","volume":"107","author":"PM Hopkins","year":"2011","unstructured":"Hopkins PM. Malignant hyperthermia: pharmacology of triggering. Br J Anaesth. 2011;107(1):48\u201356.","journal-title":"Br J Anaesth"},{"issue":"2","key":"4010_CR8","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1213\/ANE.0000000000000062","volume":"118","author":"M Visoiu","year":"2014","unstructured":"Visoiu M, et al. Anesthetic drugs and onset of malignant hyperthermia. Anesth Analg. 2014;118(2):388\u201396.","journal-title":"Anesth Analg"},{"issue":"2","key":"4010_CR9","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s00540-016-2305-z","volume":"31","author":"Safety Committee of Japanese Society of","year":"2017","unstructured":"Safety Committee of Japanese Society of. JSA guideline for the management of malignant hyperthermia crisis 2016. J Anesth. 2017;31(2):307\u201317.","journal-title":"J Anesth"},{"issue":"5","key":"4010_CR10","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1097\/ALN.0000000000002813","volume":"131","author":"CA Ibarra Moreno","year":"2019","unstructured":"Ibarra Moreno CA, et al. An Assessment of Penetrance and Clinical Expression of Malignant Hyperthermia in Individuals Carrying Diagnostic Ryanodine Receptor 1 Gene Mutations. Anesthesiology. 2019;131(5):983\u201391.","journal-title":"Anesthesiology"},{"issue":"8\u20139","key":"4010_CR11","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s00101-014-2351-6","volume":"63","author":"S Wolak","year":"2014","unstructured":"Wolak S, R\u00fccker B, Kohlschmidt N, et al. Homozygous and compound heterozygous RYR1 mutations. New findings on prevalence and penetrance of malignant hyperthermia. Anaesthesist. 2014;63(8\u20139):643\u201350. https:\/\/doi.org\/10.1007\/s00101-014-2351-6. Epub 2014 Jul 23.","journal-title":"Anaesthesist"},{"issue":"2","key":"4010_CR12","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1093\/bja\/87.2.240","volume":"87","author":"H Rueffert","year":"2001","unstructured":"Rueffert H, et al. Homozygous and heterozygous Arg614Cys mutations (1840C\u2013>T) in the ryanodine receptor gene co-segregate with malignant hyperthermia susceptibility in a German family. Br J Anaesth. 2001;87(2):240\u20135.","journal-title":"Br J Anaesth"},{"issue":"4","key":"4010_CR13","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1002\/ajmg.a.35243","volume":"158A","author":"E Kondo","year":"2012","unstructured":"Kondo E, et al. Recessive RYR1 mutations in a patient with severe congenital nemaline myopathy with ophthalomoplegia identified through massively parallel sequencing. Am J Med Genet A. 2012;158A(4):772\u20138.","journal-title":"Am J Med Genet A"},{"issue":"5","key":"4010_CR14","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405\u201324.","journal-title":"Genet Med"},{"issue":"23","key":"4010_CR15","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1056\/NEJMsr1406261","volume":"372","author":"HL Rehm","year":"2015","unstructured":"Rehm HL, et al. ClinGen\u2013the Clinical Genome Resource. N Engl J Med. 2015;372(23):2235\u201342.","journal-title":"N Engl J Med"},{"issue":"5","key":"4010_CR16","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1213\/ANE.0b013e31824a95ad","volume":"114","author":"A Kaufmann","year":"2012","unstructured":"Kaufmann A, et al. Novel double and single ryanodine receptor 1 variants in two Austrian malignant hyperthermia families. Anesth Analg. 2012;114(5):1017\u201325.","journal-title":"Anesth Analg"},{"issue":"10","key":"4010_CR17","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1002\/humu.20356","volume":"27","author":"R Robinson","year":"2006","unstructured":"Robinson R, et al. Mutations in RYR1 in malignant hyperthermia and central core disease. Hum Mutat. 2006;27(10):977\u201389.","journal-title":"Hum Mutat"},{"issue":"6","key":"4010_CR18","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.bja.2020.07.042","volume":"125","author":"CA Ibarra Moreno","year":"2020","unstructured":"Ibarra Moreno CA, et al. A multi-dimensional analysis of genotype-phenotype discordance in malignant hyperthermia susceptibility. Br J Anaesth. 2020;125(6):995\u20131001.","journal-title":"Br J Anaesth"}],"container-title":["BMC Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12871-026-04010-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-026-04010-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-026-04010-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T02:29:00Z","timestamp":1786674540000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12871-026-04010-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4010"],"URL":"https:\/\/doi.org\/10.1186\/s12871-026-04010-8","relation":{},"ISSN":["1471-2253"],"issn-type":[{"value":"1471-2253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"assertion":[{"value":"27 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the patients for the publication of their personal and clinical details, along with any identifying information, in this study.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"491"}}